We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Evaluates shortened treatment regimens, versus standard six-month treatment regimen, in individuals with drug-sensitive pulmonary TB
This review provides a panorama of the evidence and specific needs for development of a battery of complementary biomarkers
The anti-fungal drug posaconazole has shown significant activity against Trypanosoma cruzi in vitro and in vivo
Tuberculosis care at different levels of health care in Brazil in 2013
Traditional term for wine
Assesses the implementation of HIV-related interventions for patients with TB in Brazil
Advice and guidance on the health needs of migrant patients from Paraguay for healthcare practitioners.
Employment Tribunal decision.
Advice and guidance on the health needs of migrant patients from the Dominican Republic for healthcare practitioners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).